B xe9 langer F, Roussel C, Sawchyn C, St Hilaire E, Gezzar Dandashi S, Kimenyi Ishimwe A, et al. A genome-wide screen reveals that Dyrk1A kinase promotes nucleotide excision repair by preventing aberrant overexpression of cyclin D1 and p21. J Biol Chem. 2023;299:104900 pubmed publisher

Samara A, Shapira S, Lubin I, Shpilberg O, Avigad S, Granot G, et al. Deferasirox induces cyclin D1 degradation and apoptosis in mantle cell lymphoma in a reactive oxygen species- and GSK3β-dependent mechanism. Br J Haematol. 2021;: pubmed publisher

Muller A, Dickmanns A, Resch C, Schakel K, Hailfinger S, Dobbelstein M, et al. The CDK4/6-EZH2 pathway is a potential therapeutic target for psoriasis. J Clin Invest. 2020;: pubmed publisher

Choi C, Park S, Cho W, Choi D. Cyclin D1 is Associated with Radiosensitivity of Triple-Negative Breast Cancer Cells to Proton Beam Irradiation. Int J Mol Sci. 2019;20: pubmed publisher

Yu S, Lee D, Baek S, Cho D, Choi J, Kang J. Identification of mTOR inhibitor-resistant genes in cutaneous squamous cell carcinoma. Cancer Manag Res. 2018;10:6379-6389 pubmed publisher

Wang N, Wang X, Tan H, Li S, Tsang C, Tsao S, et al. Berberine Suppresses Cyclin D1 Expression through Proteasomal Degradation in Human Hepatoma Cells. Int J Mol Sci. 2016;17: pubmed

Dai M, Al Odaini A, Fils Aimé N, Villatoro M, Guo J, Arakelian A, et al. Cyclin D1 cooperates with p21 to regulate TGF?-mediated breast cancer cell migration and tumor local invasion. Breast Cancer Res. 2013;15:R49 pubmed publisher

Newman R, Mobascher A, Mangold U, Koike C, Diah S, Schmidt M, et al. Antizyme targets cyclin D1 for degradation. A novel mechanism for cell growth repression. J Biol Chem. 2004;279:41504-11 pubmed